Sara Ek

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 24

Top Topics

Histone Deacetylase

Top Venues

JMIR research protocols

NPJ precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Joana Matos Rodrigues, Lavanya Lokhande, Lina Maj Olsson, May Hassan, Angelica Johansson, Anna Janská, Darshan Kumar, Lina Schmidt, Anna Nikkarinen, Peter Hollander, Ingrid Glimelius, Anna Porwit, Anna Sandström Gerdtsson, Mats Jerkeman, Sara Ek
CD163+ macrophages in mantle cell lymphoma induce activation of prosurvival pathways and immune suppression. Blood advances 8 (16) (2024)
Emma Belfrage, Sara Ek, Åsa C M Johansson, Hanna Brauner, Andreas Sonesson, Kristina Drott
Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome (BIO-MUSE): Protocol for a Translational Study. JMIR research protocols 13 (2024)
Joana Matos Rodrigues, Lavanya Lokhande, Lina Maj Olsson, May Mostafa Hassan, Angelica Johansson, Anna Janská, Darshan Kumar, Lina Schmidt, Anna Nikkarinen, Peter Hollander, Ingrid Glimelius, Anna Porwit, Anna Sandström Gerdtsson, Mats Jerkeman, Sara Ek
CD163+ macrophages in mantle cell lymphoma induce activation of pro-survival pathways and immune suppression. Blood advances (2024)
Claudia Mateiou, Lavanya Lokhande, Lan Hoa Diep, Mattis Knulst, Elias Carlsson, Sara Ek, Karin Sundfeldt, Anna Sandström Gerdtsson
Spatial tumor immune microenvironment phenotypes in ovarian cancer. NPJ precision oncology 8 (1) (2024)
Emma Belfrage, Sara Ek, Åsa C M Johansson, Hanna Brauner, Andreas Sonesson, Kristina Drott
Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome (BIO-MUSE): Protocol for a Translational Study. JMIR research protocols 13 (2024)
Emma Belfrage, Sara Ek, Åsa C M Johansson, Hanna Brauner, Andreas Sonesson, Kristina Drott
Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome (BIO-MUSE): Protocol for a Translational Study. JMIR research protocols 13 (2024)
Lavanya Lokhande, Daniel Nilsson, Joana de Matos Rodrigues, May Hassan, Lina Maj Olsson, Paul-Theodor Pyl, Louella Vasquez, Anna Porwit, Anna Sandström Gerdtsson, Mats Jerkeman, Sara Ek
Quantification and Profiling of Early and Late Differentiation Stage T Cells in Mantle Cell Lymphoma Reveals Immunotherapeutic Targets in Subsets of Patients. Cancers 16 (13) (2024)
Claudia Mateiou, Lavanya Lokhande, Lan Hoa Diep, Mattis Knulst, Elias Carlsson, Sara Ek, Karin Sundfeldt, Anna Sandström Gerdtsson
Spatial tumor immune microenvironment phenotypes in ovarian cancer. NPJ precision oncology 8 (1) (2024)
Claudia Mateiou, Lavanya Lokhande, Lan Hoa Diep, Mattis Knulst, Elias Carlsson, Sara Ek, Karin Sundfeldt, Anna Sandström Gerdtsson
Spatial tumor immune microenvironment phenotypes in ovarian cancer. NPJ precision oncology 8 (1) (2024)
Emma Belfrage, Sara Ek, Åsa C M Johansson, Hanna Brauner, Andreas Sonesson, Kristina Drott
Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome (BIO-MUSE): Protocol for a Translational Study. JMIR research protocols 13 (2024)
Lavanya Lokhande, Daniel Nilsson, Joana de Matos Rodrigues, May Hassan, Lina Maj Olsson, Paul-Theodor Pyl, Louella Vasquez, Anna Porwit, Anna Sandström Gerdtsson, Mats Jerkeman, Sara Ek
Quantification and Profiling of Early and Late Differentiation Stage T Cells in Mantle Cell Lymphoma Reveals Immunotherapeutic Targets in Subsets of Patients. Cancers 16 (13) (2024)
Joana Matos Rodrigues, Lavanya Lokhande, Lina Maj Olsson, May Hassan, Angelica Johansson, Anna Janská, Darshan Kumar, Lina Schmidt, Anna Nikkarinen, Peter Hollander, Ingrid Glimelius, Anna Porwit, Anna Sandström Gerdtsson, Mats Jerkeman, Sara Ek
CD163+ macrophages in mantle cell lymphoma induce activation of prosurvival pathways and immune suppression. Blood advances 8 (16) (2024)
Bieke Decaesteker, Amber Louwaige, Siebe Loontiens, Fanny De Vloed, Sarah-Lee Bekaert, Juliette Roels, Suzanne Vanhauwaert, Sara De Brouwer, Ellen Sanders, Alla Berezovskaya, Geertrui Denecker, Eva D'haene, Stéphane Van Haver, Wouter Van Loocke, Jo Van Dorpe, David Creytens, Nadine Van Roy, Tim Pieters, Christophe Van Neste, Matthias Fischer, Pieter Van Vlierberghe, Stephen S Roberts, Johannes Hubertus Schulte, Sara Ek, Rogier Versteeg, Jan Koster, Johan van Nes, Mark W Zimmerman, Katleen De Preter, Frank Speleman
SOX11 regulates SWI/SNF complex components as member of the adrenergic neuroblastoma core regulatory circuitry. Nature communications 14 (1) (2023)
Eirini Kalliara, Emma Belfrage, Urban Gullberg, Kristina Drott, Sara Ek
Spatially Guided and Single Cell Tools to Map the Microenvironment in Cutaneous T-Cell Lymphoma. Cancers 15 (8) (2023)
Bieke Decaesteker, Amber Louwaige, Siebe Loontiens, Fanny De Vloed, Sarah-Lee Bekaert, Juliette Roels, Suzanne Vanhauwaert, Sara De Brouwer, Ellen Sanders, Alla Berezovskaya, Geertrui Denecker, Eva D'haene, Stéphane Van Haver, Wouter Van Loocke, Jo Van Dorpe, David Creytens, Nadine Van Roy, Tim Pieters, Christophe Van Neste, Matthias Fischer, Pieter Van Vlierberghe, Stephen S Roberts, Johannes Hubertus Schulte, Sara Ek, Rogier Versteeg, Jan Koster, Johan van Nes, Mark W Zimmerman, Katleen De Preter, Frank Speleman
SOX11 regulates SWI/SNF complex components as member of the adrenergic neuroblastoma core regulatory circuitry. Nature communications 14 (1) (2023)
Anna Nikkarinen, Lavanya Lokhande, Rose-Marie Amini, Mats Jerkeman, Anna Porwit, Daniel Molin, Gunilla Enblad, Arne Kolstad, Riikka Katariina Räty, Martin Hutchings, Caroline E Weibull, Peter Hollander, Sara Ek, Ingrid Glimelius
Soluble CD163 predicts outcome in both chemoimmunotherapy and targeted therapy-treated mantle cell lymphoma. Blood advances (2023)
Bieke Decaesteker, Amber Louwaige, Siebe Loontiens, Fanny De Vloed, Sarah-Lee Bekaert, Juliette Roels, Suzanne Vanhauwaert, Sara De Brouwer, Ellen Sanders, Alla Berezovskaya, Geertrui Denecker, Eva D'haene, Stéphane Van Haver, Wouter Van Loocke, Jo Van Dorpe, David Creytens, Nadine Van Roy, Tim Pieters, Christophe Van Neste, Matthias Fischer, Pieter Van Vlierberghe, Stephen S Roberts, Johannes Hubertus Schulte, Sara Ek, Rogier Versteeg, Jan Koster, Johan van Nes, Mark W Zimmerman, Katleen De Preter, Frank Speleman
SOX11 regulates SWI/SNF complex components as member of the adrenergic neuroblastoma core regulatory circuitry. Nature communications 14 (1) (2023)
Eirini Kalliara, Emma Belfrage, Urban Gullberg, Kristina Drott, Sara Ek
Spatially Guided and Single Cell Tools to Map the Microenvironment in Cutaneous T-Cell Lymphoma. Cancers 15 (8) (2023)
Mette Dahl, Simon Husby, Christian W Eskelund, Soren Besenbacher, Søren Fjelstrup, Christophe Rm Côme, Sara Ek, Arne Kolstad, Riikka Räty, Mats Jerkeman, Christian H Geisler, Jørgen Kjems, Lasse Sommer Kristensen, Kirsten Grønbaek
Expression patterns and prognostic potential of circular RNAs in mantle cell lymphoma: a study of younger patients from the MCL2 and MCL3 clinical trials. Leukemia (2021)
Joana Matos Rodrigues, Anna Porwit, May Hassan, Sara Ek, Mats Jerkeman
Targeted genomic investigations in a population-based cohort of mantle cell lymphoma reveal novel clinically relevant targets. Leukemia & lymphoma 62 (11) (2021)
Joana Matos Rodrigues, Anna Nikkarinen, Peter Hollander, Caroline E Weibull, Riikka Räty, Arne Kolstad, Rose-Marie Amini, Anna Porwit, Mats Jerkeman, Sara Ek, Ingrid Glimelius
Infiltration of CD163-, PD-L1- and FoxP3-positive cells adversely affects outcome in patients with mantle cell lymphoma independent of established risk factors. British journal of haematology 193 (3) (2021)
Lavanya Lokhande, Venera Kuci Emruli, Arne Kolstad, Martin Hutchings, Riikka Räty, Mats Jerkeman, Sara Ek
Immune-related protein signature in serum stratify relapsed mantle cell lymphoma patients based on risk. BMC cancer 20 (1) (2020)
Joana Matos Rodrigues, May Hassan, Catja Freiburghaus, Christian W Eskelund, Christian Geisler, Riikka Räty, Arne Kolstad, Christer Sundström, Ingrid Glimelius, Kirsten Grønbaek, Anna Kwiecinska, Anna Porwit, Mats Jerkeman, Sara Ek
p53 is associated with high-risk and pinpoints TP53 missense mutations in mantle cell lymphoma. British journal of haematology 191 (5) (2020)
Catja Freiburghaus, Venera Kuci Emruli, Angelica Johansson, Christian Winther Eskelund, Kirsten Grønbæk, Roger Olsson, Fredrik Ek, Mats Jerkeman, Sara Ek
Bortezomib prevents cytarabine resistance in MCL, which is characterized by down-regulation of dCK and up-regulation of SPIB resulting in high NF-κB activity. BMC cancer 18 (1) (2018)